Osteoporosis drug showdown: which works better for Age-Related bone loss?
Disease control
ENROLLING_BY_INVITATION
This study tests whether switching osteoporosis patients from one drug to another after one year improves bone loss. It involves 40 adults aged 45 and older who already completed a related trial. Participants will take either Alendronate or Teriparatide for one year, then switch …
Phase: PHASE4 • Sponsor: Paul F Netzel • Aim: Disease control
Last updated May 14, 2026 12:03 UTC